CompletedNot Applicable

Effect of Stellate Ganglion Block Combined With Facial Nerve Block on the Treatment of Idiopathic Facial Paralysis

China80 participantsStarted 2021-03-01

Plain-language summary

Peripheral facial palsy is caused by damage to the facial nerve at any site of the peripheral branches after the facial nucleus.Stellate ganglion block is performed to treat peripheral facial palsy because it increases blood flow and promotes nerve regeneration.Facial Nerve Block worked with elimination of local inflammation of nerve and oppression. Facial nerve block is a treatment that inject drugs into the damaged nerve around to eliminate local inflammation and compression of the nerve.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Diagnosed by clinical and neurological assessment as one-sided simple facial * Age 18 to 75 years * HBGS above Ⅳ * the course of IFP not over 7 days. Exclusion Criteria: * Coagulation dysfunction * plate plate plate shape, quantity or abnormal function * mental system diseases * Gillan-Bahrain syndrome * cancer, mumps, shingles infection, jaw facial pus lymph nodeitis, encephalitis, -cerebral hemorrhage and other diseases * local infection or systemic infectious disease at the puncture site * can not accept to nerve block

What they're measuring

Change from Baseline House-Brackmann

Timeframe: Baseline ,change from baseline House-Brackmann at 3 days,6 days,9 days,14 days,one month,two month

Change from Baseline Sunnybrook

Timeframe: Baseline,change from baseline Sunnybrook at 3 days,6 days,9 days,14 days, one month,two month

Trial details

NCT IDNCT04800666

SponsorZhuan Zhang

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-03-30

View on ClinicalTrials.gov More Peripheral Facial Palsy trials